SCHEMBL16712924

SCHEMBL16712924

COc1ccc(C(=O)Cl)cc1-c1cccc(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 1/20 0.54
▸ RORC P51449 2/20 0.48
▸ RORB Q92753 2/20 0.48
▸ HSP90AA1 P07900 1/20 0.47
▸ HSP90AB1 P08238 1/20 0.47
▸ PDE4B Q07343 2/20 0.47
▸ TUBB4A P04350 1/20 0.46
▸ TUBB P07437 1/20 0.46
▸ TUBA3C P0DPH7 1/20 0.46
▸ TUBA1B P68363 1/20 0.46
▸ TUBA4A P68366 1/20 0.46
▸ TUBB4B P68371 1/20 0.46
▸ TUBB3 Q13509 1/20 0.46
▸ TUBB2A Q13885 1/20 0.46
▸ TUBB8 Q3ZCM7 1/20 0.46
▸ TUBA3E Q6PEY2 1/20 0.46
▸ TUBA1A Q71U36 1/20 0.46
▸ TUBA1C Q9BQE3 1/20 0.46
▸ TUBB6 Q9BUF5 1/20 0.46
▸ TUBB2B Q9BVA1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6246669 0.89 PDE4D (0.54) PDE4DRORCRORBHSP90AA1HSP90AB1
SCHEMBL6934114 0.86 HSP90AA1 (0.58) HSP90AA1HSP90AB1PDE4BTUBB4ATUBB
SCHEMBL16712923 0.85 LMNA (0.51) HSP90AA1HSP90AB1TSHRSMN1; SMN2HDAC8
SCHEMBL16158860 0.84 RORC (0.50) PDE4DRORCRORBHSP90AA1HSP90AB1
SCHEMBL16712926 0.84 POLB (0.49) MAPTSMN1; SMN2HDAC8ERN1SMPD1
SCHEMBL3467803 0.83 PDE4D (0.52) PDE4DRORCRORBHSP90AA1HSP90AB1
SCHEMBL7553675 0.82 RARA (0.58) PDE4DPDE4BTUBB4ATUBBTUBA3C
SCHEMBL5099550 0.81 PDE4D (0.56) PDE4DRORCRORBPDE4BNPC1
SCHEMBL16712928 0.81 HSP90AA1 (0.49) HSP90AA1HSP90AB1NPC1MAPTTSHR
SCHEMBL8024587 0.81 PDE4D (0.55) PDE4DRORCRORBHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160272584-A1 BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS UNIVERSITY OF KANSAS (US) 2016-09-22 — — US disclosed
WO-2015070091-A1 BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS THE UNIVERSITY OF KANSAS (US) 2015-05-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272584-A1 BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P PDE4D 2888/4885RORC 3047/4885RORB 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback